ArticlePlant, cell & environment2026
A Plasmodiophora Brassicae Effector PbCBM1 Promotes Clubroot Susceptibility by Competitively Binding to AtPHB3 to Disrupt Salicylic Acid Biosynthesis in Plants.
Article in Plant, cell & environment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Plasmodiophora brassicae poses a severe threat to rapeseed (Brassica napus) production worldwide. As an obligate biotrophic pathogen, it deploys effectors to suppress host immunity, yet how these effectors manipulate plant defence, particularly salicylic acid (SA)-b-mediated immunity, remains largely unknown. In this study, a CBM1 (carbohydrate-binding module)-containing effector, PbCBM1, from P. brassicae was identified, which is secreted and suppresses INF1/BAX-induced cell death. PbCBM1-overexpressing Arabidopsis showed significantly elevated susceptibility to P. brassicae. AtPHB3 (Prohibitin 3), a key regulator of SA biosynthesis, was identified as the interactor of PbCBM1 both in vivo and in vitro. The phb3 mutant also exhibited increased susceptibility, suggesting that PbCBM1 may promote plant susceptibility by targeting AtPHB3 during pathogen infection. The subsequent results showed that PbCBM1-overexpressing plants reduced SA pathway gene expression and isochorismate/SA accumulation upon chitin treatment. Furthermore, LUC and competitive Co-IP assays revealed that PbCBM1 competes with AtICS1 (Isochorismate synthase 1) for AtPHB3 binding. Collectively, P. brassicae secretes the effector PbCBM1 to competitively target AtPHB3, disrupting AtPHB3-AtICS1 complex integrity, thereby suppressing SA biosynthesis and immunity. This study reveals a novel molecular mechanism by which a biotrophic pathogen subverts plant defence and provides potential targets for breeding clubroot-resistant rapeseed varieties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.